| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911480 | Lung Cancer | 2012 | 8 Pages |
Abstract
Higher expression of EphA2 and ephrin-A1 was more related to the female sex, reduced smoking status, adenocarcinoma, well differentiated carcinomas, p-stage IA, and EGFR gene mutations. Higher EphA2 mRNA expression in p-stage I NSCLC patients was positively related to improved prognoses. These results may reflect a tumor suppressive role for the EphA2/ephrin-A1 system in a population of patients restricted to p-stage I NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Masashi Ishikawa, Ryo Miyahara, Makoto Sonobe, Marika Horiuchi, Toshi Mennju, Ei Nakayama, Masashi Kobayashi, Ryutaro Kikuchi, Jiro Kitamura, Naoto Imamura, Cheng-Long Huang, Hiroshi Date,